litlas
Log inCreate account

Fred Ramsdell

Active 1989–2023

33
Papers
18,650
Citations
33
h-index
33
i10-index

Citations

Citations per year for Fred Ramsdell1990: 18 citations1991: 33 citations1992: 36 citations1993: 37 citations1994: 93 citations1995: 119 citations1996: 129 citations1997: 115 citations1998: 125 citations1999: 138 citations2000: 92 citations2001: 107 citations2002: 96 citations2003: 186 citations2004: 276 citations2005: 389 citations2006: 378 citations2007: 346 citations2008: 306 citations2009: 292 citations2010: 219 citations2011: 224 citations2012: 203 citations2013: 175 citations2014: 159 citations2015: 121 citations2016: 118 citations2017: 113 citations2018: 147 citations2019: 386 citations2020: 329 citations2021: 293 citations2022: 289 citations2023: 183 citations2024: 256 citations2025: 117 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,285 citing papers, 37.2% of this breakdownUnited Kingdom: 483 citing papers, 7.9% of this breakdownGermany: 417 citing papers, 6.8% of this breakdownChina: 391 citing papers, 6.4% of this breakdownJapan: 368 citing papers, 6% of this breakdownFrance: 280 citing papers, 4.6% of this breakdownCanada: 200 citing papers, 3.3% of this breakdownItaly: 199 citing papers, 3.2% of this breakdownAustralia: 163 citing papers, 2.6% of this breakdownSwitzerland: 135 citing papers, 2.2% of this breakdownNetherlands: 112 citing papers, 1.8% of this breakdownSpain: 80 citing papers, 1.3% of this breakdown
0%37.2%Other 16.7%

Institutions

Fields

  • Immunology and Microbiology59.3%
  • Medicine20.5%
  • Biochemistry, Genetics and Molecular Biology17.2%
  • Neuroscience1.8%
  • Agricultural and Biological Sciences0.3%
  • Nursing0.3%
  • Other0.6%

Topics

  • Immune Cell Function and Interaction19.4%
  • T-cell and B-cell Immunology18.5%
  • Immunotherapy and Immune Responses9.3%
  • Cancer Immunotherapy and Biomarkers2.6%
  • CAR-T cell therapy research2.5%
  • Diabetes and associated disorders2.4%
  • Other45.3%

Coauthors

All papers

Open in search
  1. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

    Authors: Craig L. Bennett, Jacinda R. Christie, Fred Ramsdell, Mary E. Brunkow, Polly J. Ferguson, Luke Whitesell, Thaddeus E. Kelly, Frank T. Saulsbury, Phillip F. Chance, Hans D. Ochs - Nature Genetics 2001 cited by 3,357

  2. An essential role for Scurfin in CD4+CD25+ T regulatory cells

    Authors: Roli Khattri, Tom Cox, Sue-Ann Yasayko, Fred Ramsdell - Nature Immunology 2003 cited by 2,828

  3. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

    Authors: Mary E. Brunkow, Eric W. Jeffery, Kathryn A. Hjerrild, Bryan Paeper, Lisa B. Clark, Sue-Ann Yasayko, John E. Wilkinson, David J. Galas, Steven F. Ziegler, Fred Ramsdell - Nature Genetics 2001 cited by 2,585

  4. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

    Authors: Robert S. Wildin, Fred Ramsdell, Jane Peake, Francesca Faravelli, Jean‐Laurent Casanova, Neil R.M. Buist, Ephrat Levy‐Lahad, Massimo Mazzella, Olivier Goulet, L Perroni, F. Dagna Bricarelli, Geoffrey C Byrne, Mark McEuen, Sean Proll, Mark W. Appleby, Mary E. Brunkow - Nature Genetics 2001 cited by 1,884

  5. Opportunities for Treg cell therapy for the treatment of human disease

    Authors: Jeffrey A. Bluestone, Brent S. McKenzie, Joshua Beilke, Fred Ramsdell - Frontiers in Immunology 2023 cited by 124

  6. Vstm3 is a member of the CD28 family and an important modulator of T‐cell function

    Authors: Steven D. Levin, David W. Taft, Cameron S. Brandt, Christoph Bucher, Edward D. Howard, Eric Chadwick, Janet Johnston, Angela Hammond, Kristen Bontadelli, Daniel Ardourel, LuAnn Hebb, Anitra C. Wolf, Thomas R. Bukowski, Mark W. Rixon, Joseph L. Kuijper, Craig Ostrander, James W. West, Janine Bilsborough, Brian A. Fox, Zeren Gao, Wenfeng Xu, Fred Ramsdell, Bruce R. Blazar, Katherine E. Lewis - European Journal of Immunology 2011 cited by 343

  7. The activation antigen CD69

    Authors: Steven F. Ziegler, Fred Ramsdell, Mark R. Alderson - Stem Cells 1994 cited by 545

  8. Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis

    Authors: Holm H. Uhlig, Janine L. Coombes, Christian Mottet, Ana Ízcue, Claire Hartmann‐Thompson, Andrea Fanger, Andrea Tannapfel, Jason D. Fontenot, Fred Ramsdell, Fiona Powrie - The Journal of Immunology 2006 cited by 448

  9. Fas ligand mediates activation-induced cell death in human T lymphocytes.

    Authors: Mark R. Alderson, Teresa W. Tough, Terri Davis‐Smith, S Braddy, Ben Falk, Ken Schooley, Raymond G. Goodwin, Craig A. Smith, Fred Ramsdell, David H. Lynch - The Journal of Experimental Medicine 1995 cited by 949

  10. Scurfin (FOXP3) Acts as a Repressor of Transcription and Regulates T Cell Activation

    Authors: Lisa Schubert, Eric W. Jeffery, Yi Zhang, Fred Ramsdell, Steven F. Ziegler - Journal of Biological Chemistry 2001 cited by 547

  11. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome

    Authors: Craig L. Bennett, Mary E. Brunkow, Fred Ramsdell, Kathy O'Briant, Qili Zhu, Ramsay Fuleihan, Ann O. Shigeoka, Hans D. Ochs, Phillip F. Chance - Immunogenetics 2001 cited by 243

  12. FOXP3 and scurfy: how it all began

    Authors: Fred Ramsdell, Steven F. Ziegler - Nature reviews. Immunology 2014 cited by 219

  13. Foxp3: a genetic foundation for regulatory T cell differentiation and function

    Authors: Fred Ramsdell, Alexander Y. Rudensky - Nature Immunology 2020 cited by 33

  14. Cellular and molecular characterization of the scurfy mouse mutant.

    Authors: Lisa B. Clark, Mark W. Appleby, Mary E. Brunkow, John E. Wilkinson, Steven F. Ziegler, Fred Ramsdell - 1999 cited by 194

  15. Cellular and Molecular Characterization of the scurfy Mouse Mutant

    Authors: Lisa B. Clark, Mark W. Appleby, Mary E. Brunkow, John E. Wilkinson, Steven F. Ziegler, Fred Ramsdell - The Journal of Immunology 1999 cited by 166

  16. Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens

    Authors: Steven F. Ziegler, Fred Ramsdell, Kathryn A. Hjerrild, Richard J. Armitage, Kenneth H. Grabstein, Kathryn B. Hennen, Terry Farrah, William C. Fanslow, Ethan M. Shevach, Mark R. Alderson - European Journal of Immunology 1993 cited by 150

  17. A Nondeletional Mechanism of Thymic Self Tolerance

    Authors: Fred Ramsdell, Tracy Lantz, B. J. Fowlkes - Science 1989 cited by 315

  18. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34.

    Authors: Peter Baum, Richard B. Gayle, Fred Ramsdell, Sundaramoorthy Srinivasan, Rick Sorensen, M. Watson, Michael F. Seldin, Elizabeth Baker, G.R. Sutherland, K N Clifford - The EMBO Journal 1994 cited by 285

  19. Fas and FasL in the homeostatic regulation of immune responses

    Authors: David H. Lynch, Fred Ramsdell, Mark R. Alderson - Immunology Today 1995 cited by 574

  20. Foxp3 and Natural Regulatory T Cells

    Authors: Fred Ramsdell - Immunity 2003 cited by 273

  21. Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage

    Authors: Ellen A. Robey, B. J. Fowlkes, Jon W. Gordon, Dimitris Kioussis, Harald von Boehmer, Fred Ramsdell, Richard Axel - Cell 1991 cited by 208

  22. Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance

    Authors: Fred Ramsdell, B. J. Fowlkes - Science 1990 cited by 366

  23. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death

    Authors: Fred Ramsdell, Michael S. Seaman, Robert E. Miller, Kathleen S. Picha, Mary K. Kennedy, David H. Lynch - International Immunology 1994 cited by 319

  24. The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex.

    Authors: SF Ziegler, Steven D. Levin, L Johnson, Neal G. Copeland, David Gilbert, Nancy A. Jenkins, Elizabeth Baker, G.R. Sutherland, Andrew L. Feldhaus, Fred Ramsdell - The Journal of Immunology 1994 cited by 130